Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver

Figure 2 Expression levels of hepcidin and ferroportin genes. A: Sustained virological response (SVR) vs non-SVR; B: Genotype 1b vs 2a/2b; C: RBV dose reduction (+) vs (−). The levels were measured by real-time reverse transcription polymerase chain reaction. ^aP< 0.05 vs SVR, ^bP < 0.01 vs SVR, ^cP < 0.05 vs control, ^dP < 0.01 vs control.